|
The range of electronic and mechanical liquid-handling
products of Biohit, which operates in the fields of biotechnology
and high technology, is these days the most diverse in the
world. Biohit produces laboratory equipment and accessories
and diagnostic test systems that are used at research institutes,
in health care and industry's laboratories. Biohit is the
global market leader in the production of electronic liquid
handling products.
In the field of diagnostics Biohit has a test panel for determining
Helicobacter pylori infection and atrophic gastritis as well
as for screening the risk of stomach cancer and gastric and
peptic ulcers from blood samples (GastroPanel). The benefits
of the test are the high sensitivity and success rate and
the speed of the results. Biohit has also developed a user-friendly
analysis programme (GastroSoft) for interpreting the results.
In addition, Biohit has tests for determining lactose intolerance
and systemic lupus erythematosus.
Biohit's instruments include microplate readers and washers.
The liquid-handling products, diagnostic tests and instruments
together enable Biohit to offer complete analyzing systems
to different types of laboratories.
Biohit, which has its eyes firmly set abroad, was established
in 1988. Last year the company's profit was 25.5 million euros.
The company has a wide international distribution network
that covers some 450 distributors in 70 countries. Biohit
has foreign subsidiaries in four European countries and in
Russia, Japan and the United States. Last year 96 per cent
of the company's turnover accumulated from abroad, a half
in European countries, 25 per cent in North America and 24
per cent in Asia. In 1999 Biohit was the first bioindustry
company to be quoted on the Helsinki Stock Exchange.


>>
www.biohit.com
|